|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Tuten Scott C/O DANIMER SCIENTIFIC, INC. 140 INDUSTRIAL BOULEVARD BAINBRIDGE, GA 39817 |
Chief Market & Sustain Officer |
/s/ Scott Tuten | 01/20/2022 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Tuten as a result of the partial vesting of the Restricted Stock Award (hereinafter defined). |
(2) | As previously disclosed, Mr. Tuten was granted 377,259 restricted shares of the Common Stock under a restricted stock award (the "Restricted Stock Award"), pursuant to the Danimer Scientific, Inc. 2020 Long-Term Incentive Plan. |
Remarks: This amendment on Form 4/A is being filed to amend the Form 4, originally filed on January 4, 2022 (the "Original Form 4"), solely to correct an error in the previously reported number of shares of Common Stock beneficially owned by Reporting Person following the reported transaction as set forth in Table I - "Amount of Securities Beneficially Owned Following Reported Transaction(s)" (Column 5). The Original Form 4 inadvertently omitted 155,392 shares of Common Stock owned directly by Reporting Person from the total reported in Table I - "Amount of Securities Beneficially Owned Following Reported Transaction(s)" (Column 5). Such 155,392 shares constitute all of Reporting's Person's shares of Common Stock that are not associated with the Restricted Stock Award and had been previously reported on Reporting Person's Section 16 filings prior to the Original Form 4. |